Welcome to our dedicated page for Movano SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Movano Inc. (Nasdaq: MOVE) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-powered summaries that help explain their contents in plain language. Movano, doing business as Movano Health, files a range of documents with the U.S. Securities and Exchange Commission that together outline its wearable health technology business, capital structure, and significant corporate events.
Investors can review registration statements such as the Form S-1 that describes a committed equity facility with Chardan Capital Markets LLC, including the potential issuance of up to 110,000,000 shares of common stock under the facility and Movano’s status as an emerging growth company and smaller reporting company. The S-1 and related materials also discuss Nasdaq listing matters, reverse stock split effects on share counts, and stockholders’ equity considerations.
Current reports on Form 8-K document material events, including the Agreement and Plan of Merger with Corvex, Inc., the structure of the all-stock combination, expected ownership percentages of the combined company, and conditions to closing. Other 8-K filings cover the one-for-ten reverse stock split, Nasdaq deficiency notices and extensions, amendments to incentive plans, preferred stock financings, amendments to loan agreements, and stockholder meeting results. These filings provide detail on how Movano is addressing listing requirements, financing needs, and its planned transformation through the Corvex merger.
Definitive proxy statements on Schedule 14A offer insight into stockholder votes on matters such as increasing authorized share capital, approving share issuances under the ChEF Purchase Agreement, amending the omnibus incentive plan, and authorizing reverse stock splits. They also describe virtual special meeting logistics and voting procedures for common and preferred stockholders.
On Stock Titan, each filing is accompanied by AI-generated highlights that point out key terms, risk factors, and structural details, helping users navigate lengthy documents like S-1 registration statements and complex 8-K merger disclosures. The platform also makes it easier to locate quarterly and annual reports when filed (Forms 10-Q and 10-K), as well as any insider transaction reports on Form 4, so users can monitor executive and director share dealings once available.
By using this page, investors can quickly find Movano’s official SEC filings related to its wearable medical devices, financing arrangements, Nasdaq compliance efforts, and the proposed renaming and repositioning of the company as Corvex, Inc. after the merger closes, while relying on AI tools to surface the most important information from each document.
Movano Inc. and Corvex filed this communication to highlight a new long-term customer deployment for Corvex ahead of their proposed all-stock merger. Corvex, an AI cloud computing company, has signed a long-term lease agreement to provide a dedicated cluster of NVIDIA H200 GPUs to an AI-driven provider of high-performance battery technologies. The GPUs will support the customer’s core AI research and production workloads.
Corvex is delivering a secure, managed on-premise GPU solution with hardware-enforced encryption, remote attestation, and telemetry designed to meet strict data-sovereignty, compliance, and intellectual property protection requirements. Its platform also includes a fully managed, hyperscaler-class Kubernetes service aimed at maximizing GPU utilization, limiting idle capacity, and simplifying operations so the customer’s engineering team can focus on building AI models. The filing also reiterates the previously announced definitive merger agreement between Movano and Corvex and directs investors to the Form S-4 and proxy statement for detailed information on the proposed transaction.
Movano Inc.'s Chief Technology Officer Michael Aaron Leabman received 11,174 shares of common stock on January 9, 2026 through a grant of restricted stock units. The RSUs were issued under the company’s Omnibus Incentive Plan in lieu of cash salary for the period from January 1, 2026 to March 31, 2026, so no cash was paid per share. Following this grant, Leabman directly beneficially owned 33,813 shares of Movano common stock.
Movano Inc.'s chief technology officer and director Michael Aaron Leabman reported selling blocks of common stock in three transactions. On January 12, 2026, he sold 3,377 shares at a weighted average price of $7.01, followed by 2,076 shares at $6.94 on January 13 and 6,845 shares at $6.66 on January 14. The filing states these shares were sold to pay withholding taxes and exercise prices tied to stock option awards granted in lieu of cash salary during 2025. After these sales, he directly holds 22,639 Movano common shares.
Movano Inc. (MOVE) filed an insider trading report showing its Chief Executive Officer and director, John Mastrototaro, receiving additional equity compensation. On January 9, 2026, he was granted 11,919 shares of common stock at a price of $0.00 per share, reported as a receipt of restricted stock units under the company’s Omnibus Incentive Plan. The grant was made in lieu of cash salary for the period from January 1, 2026 to March 31, 2026. Following this award, Mastrototaro beneficially owned 16,349 shares of Movano common stock, held directly.
Movano Inc. filed an S-1 covering the resale of up to 110,000,000 shares of common stock that may be issued to Chardan under a committed equity facility, plus 545,456 shares issuable on conversion of Series A Preferred Stock held by selling stockholders. Movano is not selling shares itself in this prospectus and will not receive proceeds from resales by these holders.
The Series A financing provided
Movano recently effected a one‑for‑ten reverse split and faces Nasdaq delisting risk after reporting stockholders’ equity of approximately
Movano Inc. director Emily Fairbairn reported equity compensation and holdings in company stock. On January 9, 2026, she received grants of 4,470 restricted stock units (RSUs) under the company’s Omnibus Incentive Plan in lieu of cash directors’ fees for the period from January 1, 2026 to June 30, 2026, and a separate grant of 5,959 RSUs for the same period. Both grants were reported at a price of $0 per share, reflecting that they are non-cash awards.
Following these awards, Fairbairn reported 13,119 shares of Movano common stock held directly. She also reported indirect holdings of 33,232 shares held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust, over which she has voting and investment power while disclaiming beneficial ownership except for her and her spouse’s pecuniary interest, and 3,522 shares held by Valley High Limited Partnership, over which she also has voting and investment power.
Movano Inc. director Brian Cullinan reported stock-based compensation. On January 9, 2026, he received two grants tied to service under the company’s Omnibus Incentive Plan for the period from January 1, 2026 to June 30, 2026.
The filing shows a grant of 4,768 restricted stock units (RSUs) in lieu of cash directors’ fees for that period, and a separate grant of 2,980 RSUs for the same service period. Both entries are recorded at a price of $0.00 per share. After these awards, Cullinan is shown as beneficially owning 9,622 shares of Movano common stock, held directly.
Movano Inc. director Ruben Caballero reported receiving equity compensation instead of cash fees. On January 9, 2026, he acquired 2,980 shares of common stock at $0 per share, with the footnote explaining this reflects a grant of 2,980 restricted stock units (RSUs) under the Omnibus Incentive Plan in lieu of cash directors’ fees for the period from January 1, 2026 to June 30, 2026. A second transaction that same day reports another acquisition of 2,980 shares at $0 per share, tied to a separate grant of 2,980 RSUs for the same period. Following these grants, Caballero beneficially owned 6,495 shares of Movano common stock directly.
Movano Inc. director Shaheen Wirk reported stock-based compensation rather than a cash payment. On January 9, 2026, Wirk received a grant of 2,980 restricted stock units (RSUs) under Movano’s Omnibus Incentive Plan in lieu of cash directors’ fees for the period from January 1, 2026 to June 30, 2026. On the same date, Wirk received a separate grant of 2,980 RSUs under the same plan for service over that same January 1, 2026 to June 30, 2026 period.
Both transactions are reported at a price of $0 per share, reflecting equity compensation rather than a market purchase. Following these grants, Wirk is shown as beneficially owning 5,860 shares of Movano common stock directly.
Movano Inc. director and Chief Technology Officer Michael Aaron Leabman reported exercising stock options and related share sales. On January 6, 2026, he exercised 42,250 stock options at an exercise price of $1.25 per share, receiving the same number of Movano common shares. On January 7, 8, and 9, 2026, he sold 3,293, 3,593, and 783 shares, respectively, at weighted average prices of $7.34, $7.26, and $7.27 per share, with the filing noting that shares were sold to pay withholding taxes and exercise costs tied to option awards received in lieu of 2025 cash salary. After these transactions, Leabman directly held 34,937 shares of Movano common stock. The filing also states that the option award became exercisable following shareholder approval of an amendment to the Omnibus Incentive Plan on December 16, 2025.
FAQ
What is the current stock price of Movano (MOVE)?
What is the market cap of Movano (MOVE)?
